1.37
price down icon2.14%   -0.03
after-market 시간 외 거래: 1.36 -0.01 -0.73%
loading
전일 마감가:
$1.40
열려 있는:
$1.38
하루 거래량:
2.08M
Relative Volume:
0.66
시가총액:
$1.09B
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-7.2105
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
+1.48%
1개월 성능:
+7.87%
6개월 성능:
-7.43%
1년 성능:
-3.52%
1일 변동 폭
Value
$1.36
$1.3958
1주일 범위
Value
$1.34
$1.45
52주 변동 폭
Value
$1.21
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
명칭
Opko Health Inc
Name
전화
305-575-4181
Name
주소
4400 BISCAYNE BLVD., MIAMI, FL
Name
직원
2,997
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
OPK's Discussions on Twitter

OPK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
OPK
Opko Health Inc
1.37 1.11B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
478.32 179.32B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
205.48 145.22B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
565.19 44.23B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
199.17 34.14B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.18 34.19B 6.63B 1.17B 1.19B 4.05

Opko Health Inc Stock (OPK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-25 개시 JP Morgan Neutral
2023-06-29 업그레이드 Barrington Research Mkt Perform → Outperform
2022-12-15 개시 H.C. Wainwright Buy
2022-01-24 다운그레이드 Barrington Research Outperform → Mkt Perform
2021-06-21 개시 Ladenburg Thalmann Buy
2019-11-25 개시 Piper Jaffray Overweight
2018-03-02 다운그레이드 JP Morgan Neutral → Underweight
2017-09-14 다운그레이드 JP Morgan Overweight → Neutral
2016-06-21 재확인 Standpoint Research Buy
2016-06-03 개시 Standpoint Research Buy
2016-03-31 재확인 Barrington Research Outperform
2015-10-16 개시 JP Morgan Overweight
2015-09-11 다운그레이드 Jefferies Buy → Hold
2015-03-03 다운그레이드 Oppenheimer Outperform → Perform
2014-05-12 재확인 Oppenheimer Outperform
2014-03-14 개시 Oppenheimer Outperform
2013-11-13 재확인 Ladenburg Thalmann Buy
2013-05-30 재확인 Ladenburg Thalmann Buy
2012-10-22 개시 Barrington Research Outperform
2011-12-01 재확인 Ladenburg Thalmann Buy
2011-07-14 개시 Ladenburg Thalmann Buy
모두보기

Opko Health Inc 주식(OPK)의 최신 뉴스

pulisher
02:25 AM

What drives OPKO Health Inc. stock priceExplosive capital appreciation - PrintWeekIndia

02:25 AM
pulisher
06:28 AM

Is OPKO Health Inc. stock a good hedge against inflationDynamic capital growth - jammulinksnews.com

06:28 AM
pulisher
Jul 24, 2025

OPKO Health to Report Second Quarter 2025 Financial Results on July 31 - OPKO Health, Inc.

Jul 24, 2025
pulisher
Jul 24, 2025

Investors in OPKO Health (NASDAQ:OPK) From Five Years Ago Are Still Down 75%, Even After 5.1% Gain This Past Week - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

The recent 5.1% gain must have brightened CEO Phillip Frost's week, OPKO Health, Inc.'s (NASDAQ:OPK) most bullish insider - simplywall.st

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about OPKO Health Inc. stockTurbocharged investment results - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

Is OPKO Health Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

OPKO Health Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025
pulisher
Jul 21, 2025

Quote - OPKO Health, Inc.

Jul 21, 2025
pulisher
Jul 18, 2025

How high can OPKO Health Inc. stock price go in 2025Predictable Return Stock Picks - beatles.ru

Jul 18, 2025
pulisher
Jul 17, 2025

Is now a good time buy $OPK - AInvest

Jul 17, 2025
pulisher
Jul 14, 2025

OPKO Health (NASDAQ:OPK) Stock Rating Upgraded by LADENBURG THALM/SH SH - MarketBeat

Jul 14, 2025
pulisher
Jul 14, 2025

OPKO Health, Inc. (NASDAQ:OPK) Receives $2.75 Consensus Price Target from Analysts - MarketBeat

Jul 14, 2025
pulisher
Jul 11, 2025

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3 - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Opko Health (OPK) Has a New Rating from Ladenburg Thalmann & Co. - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Capital Advisors Inc. OK Increases Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jul 11, 2025
pulisher
Jul 08, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of - GlobeNewswire

Jul 08, 2025
pulisher
Jul 08, 2025

OPKO Health and Entera Bio abstract selected for ESPEN Congress - StreetInsider

Jul 08, 2025
pulisher
Jul 08, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress - Yahoo Finance

Jul 08, 2025
pulisher
Jul 08, 2025

Breakthrough: First-Ever Oral Tablet Could Replace Daily Injections for Short Bowel Syndrome Treatment - Stock Titan

Jul 08, 2025
pulisher
Jul 06, 2025

13 Stocks Under $5 With High Upside Potential - Insider Monkey

Jul 06, 2025
pulisher
Jul 04, 2025

Investor Network: OPKO Health, Inc. to Host Earnings Call - ACCESS Newswire

Jul 04, 2025
pulisher
Jun 30, 2025

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - MSN

Jun 30, 2025
pulisher
Jun 30, 2025

OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation - AInvest

Jun 30, 2025
pulisher
Jun 29, 2025

The Next Wave in Obesity Treatment: OPKO's OPK-88006 and Its Dual-Format Strategy - AInvest

Jun 29, 2025

Opko Health Inc (OPK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Opko Health Inc 주식 (OPK) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 08 '25
Buy
1.48
125,000
184,650
213,876,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 01 '25
Buy
1.65
100,000
164,850
213,751,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 28 '25
Buy
1.70
150,000
254,385
213,651,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 17 '25
Buy
1.74
200,000
347,820
213,501,448
FROST PHILLIP MD ET AL
CEO & Chairman
Feb 28 '25
Buy
1.71
67,434
115,312
213,301,448
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 28 '25
Buy
1.47
47,537
70,060
213,234,014
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 17 '25
Buy
1.47
150,000
220,425
213,186,477
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 15 '25
Buy
1.48
500,000
740,850
213,036,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 13 '24
Buy
1.59
125,000
199,375
212,536,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 11 '24
Buy
1.56
500,000
781,050
212,411,477
diagnostics_research WAT
$302.95
price up icon 1.50%
diagnostics_research DGX
$168.55
price down icon 1.95%
$138.90
price down icon 1.53%
diagnostics_research LH
$264.96
price down icon 1.02%
diagnostics_research MTD
$1,263.99
price up icon 0.26%
diagnostics_research A
$120.18
price down icon 0.14%
자본화:     |  볼륨(24시간):